Drugs that contain Amprenavir
1. Agenerase patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5585397 | GLAXOSMITHKLINE | Sulfonamide inhibitors of aspartyl protease |
Dec, 2013
(10 years ago) | |
| US5646180 | GLAXOSMITHKLINE | Treatment of the CNS effects of HIV |
Jul, 2014
(9 years ago) | |
| US5723490 | GLAXOSMITHKLINE | THF-containing sulfonamide inhibitors of aspartyl protease |
Mar, 2015
(9 years ago) | |
| US6730679 | GLAXOSMITHKLINE | Pharmaceutical formulations |
Nov, 2017
(6 years ago) | |
Market Authorisation Date: 15 April, 1999
Treatment: Treatment of hiv infection
Dosage: CAPSULE;ORAL; SOLUTION;ORAL
More Information on Dosage
AGENERASE family patents
